BACKGROUND: Current statistical prognostic models for mortality after liver transplantation do not have good discriminatory ability. Furthermore, the methodology used to develop these models is often flawed. The objective of this paper is to develop a prognostic model for 90-day mortality after liver transplantation based on pretransplant recipient factors, employing a rigorous model development method. METHODS: We used data on 4,829 patient that were prospectively collected for the UK & Ireland Liver Transplant Audit. Switching regression was employed to impute missing values combined with a bootstrapping approach for variable selection. RESULTS: In all, 452 patients (9.4%) died within 90 days of their transplantation. The final prognostic...
Background Outcome after liver transplantation (LT) is determined by donor, transplant and recipient...
BACKGROUND: The scarcity of grafts available necessitates a system that considers expected posttrans...
BACKGROUND: The Model for End-stage Liver Disease (MELD) has been used as a prognostic tool since 20...
OBJECTIVES: Liver transplantation has not increased with the number of patients requiring this treat...
Background Mortality after liver transplantation depends on heterogeneous recipient and donor factor...
BACKGROUND: Although there were some reports predicting postoperative morbidity and mortality in pat...
International audienceBACKGROUND:Acute-on-chronic liver failure (ACLF) is associated with a signific...
BACKGROUND: Risk models for mortality after liver transplantation have poor predictive ability. We e...
It has been shown that the model for end-stage liver disease (MELD) score is an accurate predictor o...
Model of end-stage liver disease (MELD)-score and diverse variants are widely used for prognosis on ...
Model of end-stage liver disease (MELD)-score and diverse variants are widely used for prognosis on ...
BACKGROUND: Mortality after liver transplantation depends on heterogeneous recipient and donor fact...
AbstractBackgroundThe Model for End‐stage Liver Disease (MELD) has been used as a prognostic tool si...
Liver transplantation is the only curative treatment for end-stage liver disease. While waiting list...
Background: The pre-transplant model for end-stage liver disease (pre-MELD) score is controversial ...
Background Outcome after liver transplantation (LT) is determined by donor, transplant and recipient...
BACKGROUND: The scarcity of grafts available necessitates a system that considers expected posttrans...
BACKGROUND: The Model for End-stage Liver Disease (MELD) has been used as a prognostic tool since 20...
OBJECTIVES: Liver transplantation has not increased with the number of patients requiring this treat...
Background Mortality after liver transplantation depends on heterogeneous recipient and donor factor...
BACKGROUND: Although there were some reports predicting postoperative morbidity and mortality in pat...
International audienceBACKGROUND:Acute-on-chronic liver failure (ACLF) is associated with a signific...
BACKGROUND: Risk models for mortality after liver transplantation have poor predictive ability. We e...
It has been shown that the model for end-stage liver disease (MELD) score is an accurate predictor o...
Model of end-stage liver disease (MELD)-score and diverse variants are widely used for prognosis on ...
Model of end-stage liver disease (MELD)-score and diverse variants are widely used for prognosis on ...
BACKGROUND: Mortality after liver transplantation depends on heterogeneous recipient and donor fact...
AbstractBackgroundThe Model for End‐stage Liver Disease (MELD) has been used as a prognostic tool si...
Liver transplantation is the only curative treatment for end-stage liver disease. While waiting list...
Background: The pre-transplant model for end-stage liver disease (pre-MELD) score is controversial ...
Background Outcome after liver transplantation (LT) is determined by donor, transplant and recipient...
BACKGROUND: The scarcity of grafts available necessitates a system that considers expected posttrans...
BACKGROUND: The Model for End-stage Liver Disease (MELD) has been used as a prognostic tool since 20...